TrialScientific reports2025

Exome sequencing shows same pattern of clonal tumor mutational burden, intratumor heterogenicity and clonal neoantigen between autologous tumor and Vigil product.

David Willoughby et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.